Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5463_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
12.10.2026
Размер:
6 Мб
Скачать
☆
258
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
 
Xu et al., 2008).
-


      
       

-

organs and is able to achieve the required drug concentration around the



        
  

          



          
produce comparatively better cell death percentage and tumor inhibition rate


8.4.4 MISCELLANEOUS


          
         





        

Nanofiber Technology in Biomedical Applications
259


       
        
         -



-







-

-






-

al., 2006).

8.5 DRUG DELIVERY APPLICATION

      

260
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
TABLE 8.2 Drug Delivery Application.
Drug classification System name Drug used Polymer used References
Antihypertensive drug 

Valsartan Polyvinylpyrrolidone
K-90 (PVP K-90)

2021
 Irbesartan PVP K-90 Adeli, 2015
Biodegradable composite

Captopril and

Poly(l-lactic acid) (PLLA) Wei et al., 2011


 PVP K-90 and l-arginine 
2021
Antimicrobial drug   PVA and poly(ethylene
oxide)

2012
  Pullulan 
  PCL Monteiro et al., 2017
   PVA, CS, and hyaluronic
acid
Hosseini et al., 2021
Buccal adhesive double-

hGH Eudragit and CS Choi et al., 2016
Miscellaneous  Curcumin and

Almond gum and PVA 
2019
 Resveratrol CS and gellan Rostami et al., 2019
  CS Behbood et al., 2018
 Indomethacin Eudragit S and Eudragit
RS
Akhgari et al., 2017
Nanofiber Technology in Biomedical Applications
261

8.5.1 ANTIHYPERTENSIVE DRUG

        
        


-

          
         
-






  

          

        


   



  


      
-

 
      
 


262
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
    

drugs. So, all the results conclude that the compound antihypertensive drugs


        


          
         
          
     
          

 


8.5.2 ANTIMICROBIAL DRUG

      




to exhibit antimicrobial activity against the Escherichia coli, P. aeruginosa,
Aspergillus niger, Penicillium notatum, and Aspergillus flavus. So, this


       
antimicrobial agent by the electrospinning technology using pullulan
          
(21–25)
Pal


       
    
E. coli         


Nanofiber Technology in Biomedical Applications
263
-

        
      

        
Aggre-
gatibacter actinomycetemcomitans and Porphyromonas gingivalis and they
       

delivery (Monteiro et al., 2017).

8.5.3 GROWTH HORMONE



and hyaluronic acid polymers due to their biodegradability , biocompatibility ,
   


        


     

-
       
hormones (Hosseini et al., 2021).


      

       -
        
      
         


264
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2

materials (Choi et al., 2016).

8.5.4 MISCELLANEOUS



 

          
     
R
2
value greater than 0.9176. So, it

and Nasirpour, 2019).
    -





          

   

       

 

    
    
-
    

         


     
 
Nanofiber Technology in Biomedical Applications
265
   

         

 -



8.6 CONCLUSION

 
        
        
         
  -

      
tissue regeneration. Recently, several studies have reported its applications

        



     
     
  


KEYWORDS

• nanofiber
• electrospun
• drug delivery
• biopolymer
• wound healing
266
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2

REFERENCES


    
Jundishapur J. Microbiol. 2015, 8 (10).

   J.
Appl. Polym. Sci. 2015, 132 (27).
     
      
Evaluation and in Vitro Healing Assay. Int. J. Biol. Macromol. 2019, 122, 238–254.


Dissolution Studies. Colloids Surfaces B: Biointerfaces 2017, 152, 29–35.

Biomedical Applications. Nanomaterials 2018, 8 (4), 259.
       
J. Text. Assoc. 2017,
78 (1), 5–14.
1934.


Biochemistry (Moscow) 2003, 68 (11), 1261–1266.

Proceedings of the 3rd International Conference
on Nanotechnology-Smart Materials (NANOCON’11)2011.

Filtering Media. J. Membr. Sci. 2006, 283 (1–2), 209–218.

     
Delivery System. Fibers Polym. 2018, 19 (7), 1454–1462.
    
Adv. Mater. 1999, 11 (16), 1362–1365.
      
Biotechnol. Adv . 2010, 28 (3), 325–347.
             
Pharmaceutics 2018, 11 (1), 5.
  
Pharm. Dev. Technol. 2021, 26 (6), 661–672.

J. Pharm. Sci. 2008, 97 (8), 2892–2923.
     
Adv. Mater. 2001,
13 (1), 70–72.

Nature 2003, 424 (6950), 805–808.
Nanofiber Technology in Biomedical Applications
267

J. Biomed. Mater. Res. Part B: Appl. Biomater . 2016,
104 (7), 1396–1406.

Polymer 2001, 42 (1), 261–272.
    
Polymer 2002, 43 (11), 3303–3309.
     
Nanoscale 2014, 6 (16), 9477–9493.

      

Death. Int. J. Biol. Macromol. 2020, 164, 1461–1474.

and Biomedical Applications. Artif. Cells Nanomed. Biotechnol. 2016, 44 (1), 111–121.
            
      
Fibers Polym. 2012, 13 (6), 709–717.
J. Cell Biol. 1972, 54
(3), 626–637.
Nanofibers-
Prod. Propert. Funct. Appl. 2011, 14, 287–302.
               
     Chem. Rev.
2005, 105 (4), 1171–1196.


Engineering. Int. J. Biol. Macromol. 2017, 102, 1174–1185.
Sci. Am. 2002, 3.
        
Polym. Adv .
Technol. 2018, 29 (12), 2972–2981.
Phys. Status Solidi
(a). 2007, 204 (6), 1830–1834.
       

Biotechnology. Arabian J. Chem. 2018, 11 (8), 1165–1188.
           
PNAS 2002, 99 (8), 5133–5138.

        
Investigations. Polym. Adv . Technol. 2021, 32 (2), 574–581.
       

a PLLA–Dioxane–Water System. J. Biomed. Mater. Res.: Off. J. Soc. Biomater. Jpn. Soc.
Biomater. Austr. Soc. Biomater. Korean Soc. Biomater. 2002, 63 (2), 161–167.